NEUTRALIZING ANTI-SARS-COV-2 ANTIBODIES

This disclosure provides novel neutralizing anti-SARS-CoV-2 antibodies or antigen-binding fragments thereof. The disclosed anti-SARS-CoV-2 antibodies constitute a novel therapeutic strategy in protection from SARS-CoV-2 infections..

Media Type:

Patent

Year of Publication:

2023

Publication:

2023

Contained In:

Europäisches Patentamt - (2023) vom: 22. Nov. To Main Record - year:2023

Language:

English

Contributors:

NUSSENZWEIG MICHEL [Author]
WANG ZIJUN [Author]

Links:

Volltext [kostenfrei]

Keywords:

Additional keywords:
615
A61K: Preparations for medical, dental, or toilet purpose (...)
A61P: Specific therapeutic activity of chemical compounds (...)
C07K: Peptides (peptides containing β-lactam rings c07d; (...)
che
G01N: Investigating or analysing materials by determining (...)
tec

Notes:

Source: www.epo.org (no modifications made), First posted: 2023-11-22, Last update posted on www.tib.eu: 2023-12-06, Last updated: 2023-12-15

Patent number:

EP4277926

Supporting institution / Project title:

PPN (Catalogue-ID):

EPA018649998